Characterization of the L-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder

被引:36
作者
Cozzi, Anna
Santambrogio, Paolo
Corsi, Barbara
Campanella, Alessandro
Arosio, Paolo
Levi, Sonia
机构
[1] Univ Vita Salute San Raffaele, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, DIBIT, I-20132 Milan, Italy
[3] Univ Brescia, Sect Chem, Fac Med, I-25100 Brescia, Italy
关键词
hereditary ferritinopathy; ferritin; iron; oxidative stress;
D O I
10.1016/j.nbd.2006.05.004
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Hereditary ferritinopathies are dominant inherited movement disorders associated with extensive alterations of the L-ferritin C-terminus peptide caused by nucleotide insertions in L-ferritin gene (FTL). We describe the characterization of the most common variant, produced by the 460InsA mutations and here named Ln1. The recombinant Ln1 assembled into 24-mer ferritin shells with low efficiency, however, it was able to form heteropolymers that showed a reduced capacity to incorporate iron in vitro. The Ln1 expressed in HeLa cells formed hybrid ferritins, with the endogenous H and L chains, and caused an iron excess phenotype. Ferritin inactivation and faster degradation in Ln1 transfectants concurred in increasing iron availability, which was probably responsible for the higher sensitivity to H2O2 toxicity and higher level of oxidized proteins. The findings suggest that the pathogenic effects of Ln1 expression are more likely due to deregulation of cellular iron homeostasis rather than to protein conformational problems. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:644 / 652
页数:9
相关论文
共 34 条
[1]
Ferritin, iron homeostasis, and oxidative damage [J].
Arosio, P ;
Levi, S .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (04) :457-463
[2]
The putative "nucleation site" in human H-chain ferritin is not required for mineralization of the iron core [J].
Bou-Abdallah, F ;
Biasiotto, G ;
Arosio, P ;
Chasteen, ND .
BIOCHEMISTRY, 2004, 43 (14) :4332-4337
[4]
Neuroferritinopathy in a French family with late onset dominant dystonia -: art. no. e69 [J].
Chinnery, PF ;
Curtis, ARJ ;
Fey, C ;
Coulthard, A ;
Crompton, D ;
Curtis, A ;
Lombès, A ;
Burn, J .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (05) :e69
[5]
CONNOR JR, 1995, J NEUROCHEM, V65, P717
[6]
DEVELOPMENT OF AN IMMUNOASSAY FOR ALL HUMAN ISOFERRITINS, AND ITS APPLICATION TO SERUM FERRITIN EVALUATION [J].
COZZI, A ;
LEVI, S ;
BAZZIGALUPPI, E ;
RUGGERI, G ;
AROSIO, P .
CLINICA CHIMICA ACTA, 1989, 184 (03) :197-206
[7]
Overexpression of wild type and mutated human ferritin H-chain in HeLa cells -: In vivo role of ferritin ferroxidase activity [J].
Cozzi, A ;
Corsi, B ;
Levi, S ;
Santambrogio, P ;
Albertini, A ;
Arosio, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25122-25129
[8]
Role of iron and ferritin in TNFα-induced apoptosis in HeLa cells [J].
Cozzi, A ;
Levi, S ;
Corsi, B ;
Santambrogio, P ;
Campanella, A ;
Gerardi, G ;
Arosio, P .
FEBS LETTERS, 2003, 537 (1-3) :187-192
[9]
Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin [J].
Cozzi, A ;
Corsi, B ;
Levi, S ;
Santambrogio, P ;
Biasiotto, G ;
Arosio, P .
BLOOD, 2004, 103 (06) :2377-2383
[10]
Case report: a subject with a mutation in the ATG start codon of L-ferritin has no haematological or neurological symptoms [J].
Cremonesi, L ;
Cozzi, A ;
Girelli, D ;
Ferrari, F ;
Fermo, I ;
Foglieni, B ;
Levi, S ;
Bozzini, C ;
Camparini, M ;
Ferrari, M ;
Arosio, P .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (06) :e81